Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data LiveOne, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Revenue
0.23
7.2
33.7
38.7
65.2
117
99.6
118
114
77.1
Cost of revenue
0.73
6.69
31.2
93
66.8
86.4
85.2
64.9
Gross profit
-0.51
0.5
2.53
24
32.8
32
29.2
12.3
Research and development
9.68
8.09
5.14
4.68
4.48
2.4
Selling, general and administrative
5.35
Selling and marketing
0.09
0.66
4.53
6.26
9.52
14.1
8.3
7.84
6.4
4.04
General and administrative
4.89
10.7
17.4
19.1
20.8
33.7
15.9
22.3
22.7
20.7
Operating expenses
5.71
22.1
67.6
74.7
94.6
155
Operating income
-5.49
-14.9
-33.9
-36
-29.4
-37.9
-2.18
-4.67
-18.1
-15.5
Interest expense
2.3
2.4
0.3
Other non-operating income
-8.77
-4.14
-3.65
-3.12
-12.8
-5.88
-7.77
-8.53
-2.5
-5.74
Pre-tax income
-14.3
-19
-37.5
-39.1
-42.2
-43.7
-9.95
-13.2
-20.6
-21.2
Income tax
0.01
0.22
-0.19
-0.35
0.18
0.07
0.12
-0.19
0.03
Income from continuing operations
-14.3
-19
-37.8
Net income to minority interests
41.8
43.9
0
-1.35
-1.66
-0.29
Net income
-14.3
-23.3
-37.8
-38.9
-41.8
-43.9
-10
-12
-18.7
-21
EBITDA
-5.46
-12.3
-26.5
-28
-20.6
-28.2
5.79
0.44
-12.7
-13.9
EPS, basic
-4.71
-6.31
-7.81
-6.53
-5.99
-1.28
-1.50
-2.14
-2.02
EPS, diluted
-4.71
-6.31
-7.81
-6.53
-5.99
-1.28
-1.50
-2.14
-2.02
Shares, basic (weighted)
3,040
3.7
4.85
56.2
6.45
7.39
7.92
8.19
9.5
11
Shares, diluted (weighted)
3,040
3.7
4.85
56.2
6.45
7.39
7.92
8.19
9.5
11
Balance sheet
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Cash and equivalents
1.48
10.3
13.7
5.7
18.6
12.9
8.41
6.99
4.12
5.35
Receivables
2.99
4.31
3.89
10.6
13.7
13.7
13.2
8.3
8.44
Inventory
2.57
2.6
2.6
1.8
1.59
0.69
Other current assets
0.02
1.76
1.31
1.4
3.37
1.87
2.82
2.19
1.21
2.27
Total current assets
1.5
18.7
19.6
17.7
35.3
31.3
27.7
24.3
15.2
16.8
Property, plant and equipment
0.06
0.39
2.72
3.4
4.37
3.33
3.33
3.65
0.89
3.3
Lease right-of-use assets
0.73
0.42
0.09
0.1
0.23
Goodwill
5.38
9.67
9.67
22.6
23.4
23.4
23.4
21.7
21.7
Intangible assets
43.5
26.9
23.2
22.5
16.7
11
12.4
2.57
1.92
Other non-current assets
43.5
26.9
0.13
1.04
0.73
0.42
0.09
0.1
0.23
Total assets
1.56
68
58.9
54.1
85.8
76.8
65.9
63.9
40.5
46.9
Accounts payable
0.54
11
18.3
26.7
18.5
29.6
11
15.2
15.3
15.7
Accrued liabilities
1.16
2.52
3.94
13.8
15.5
11.5
11.7
9.91
11.9
Deferred revenue
1.05
1.05
0.95
1.26
1.16
0.99
0.73
2.14
1.79
Short-term debt
2.11
2.72
Total current liabilities
4.73
25.7
34.2
47.8
51
60.1
44.5
46.8
36.4
35.9
Long-term debt
10.3
6.51
0.89
26.7
0.15
0.77
0.15
0.15
Lease liabilities
0.47
0.16
0
0.1
0.13
Other non-current liabilities
0.17
9.58
9.35
12.2
11.4
Total liabilities
4.96
29.6
49.4
61.2
77.6
87.7
62.1
57.3
48.9
59.3
Total debt
0.29
12.4
9.23
28.1
Paid-in capital
24.7
89.8
98.6
121
178
203
209
216
234
259
Retained earnings
-28.1
-51.4
-89.2
-128
-170
-214
-224
-239
-265
-287
Treasury stock
-2.16
-4.78
-0.25
-0.85
Shareholders' equity
-3.41
38.4
9.46
-7.13
8.14
-10.9
-1.01
-8.74
-17.8
-20.5
Minority interests
0
10.3
9.36
8.16
Total equity
-3.41
38.4
9.46
-7.13
8.14
-10.9
-1.01
1.6
-8.41
-12.4
Total liabilities and equity
1.56
68
58.9
54.1
85.8
76.8
65.9
63.9
40.5
46.9
Shares outstanding
3,240
4.81
4.89
59
7.18
7.71
8.17
8.64
9.67
12.4
Cash flow statement
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Net income
-14.3
-23.3
-37.8
-38.9
-41.8
-43.9
-10
-13.3
-20.4
-21.3
Depreciation and amortization
0.02
2.54
7.39
8.02
8.77
9.62
7.97
5.11
5.33
1.63
Stock-based compensation
0
3.22
9.22
12
11.3
12.7
3.05
6.34
6.16
11.2
Deferred income tax
0.21
-0.21
-0.36
0.16
-0.01
0.01
-0.28
0
Change in receivables
0.35
-1.32
0.53
3.43
-3.12
0.03
-0.03
4.87
0.18
Change in inventory
0.03
-0.03
0
0.8
0.22
0.9
Change in payables
0.32
2.39
11
13.2
2.33
10.8
-0.38
Cash from operations
-3.12
-5.73
-5.77
-4.89
-9.51
-9.12
-3.84
6.85
6.37
-10.5
Capital expenditures
-0.02
-0.05
-2.53
-2.58
-3.21
-3.74
-2.44
-3.04
-3.05
-3.18
Acquisitions
-0.15
Cash from investing
2.16
-2.31
-2.53
-2.44
-0.79
-3.98
-2.45
-4.05
-3.12
-8.18
Debt repaid
-1.67
-10.8
Stock issued
1.38
7.53
0.87
0
0.01
0
9.38
Share buybacks
-2.16
-2.62
-1
-0.6
Dividends paid
0
-0.51
0
Cash from financing
2.4
20.5
8.27
5.83
16.6
7.49
1.79
-4.31
-6.24
20
Net change in cash
1.44
12.5
-0.03
-1.5
6.33
-5.62
-4.51
-1.51
-2.99
1.23
Free cash flow
-3.14
-5.78
-8.3
-7.47
-12.7
-12.9
-6.28
3.81
3.32
-13.7
Interest paid
0.3
0.98
1.52
0.97
1.47
1.93
1.11
0.87
2.3
Income taxes paid
0
0.02
0.03
0
0.04
0
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $2.34 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
17.9%
Gross profit / revenue.
Operating margin
-19.6%
Operating income / revenue.
EBITDA margin
-16.9%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-26.5%
Pre-tax income / revenue.
Net margin
-25.8%
Net income / revenue.
FCF margin
-16.3%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-12.4%
Cash from operations / revenue.
Return on assets (ROA)
-41.0%
Net income / average total assets.
R&D / revenue
3.2%
Research and development expense / revenue.
Stock-based pay / revenue
20.8%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
3.9%
Capital expenditures / revenue.
D&A / revenue
2.7%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-32.6%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-8.2%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
3.4%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-57.9%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-27.9%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y
-265.6%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
-513.9%
Free cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
15.7%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-10.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-11.4%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
15.6%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
11.5%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
11.2%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.62x
Current assets / current liabilities.
Quick ratio
0.50x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.25x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$1.50
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$5.82
Revenue / diluted weighted shares.
FCF per share
-$0.95
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.72
Cash from operations / diluted weighted shares.
Book value per share
-$1.00
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.42x
Market cap / revenue.
EV/Sales
0.30x
Enterprise value / revenue.
FCF yield
-39.2%
Free cash flow / market cap.
Earnings yield
-62.2%
Net income / market cap (the inverse of P/E).
Shareholder yield
1.1%
(Dividends paid + share buybacks) / market cap.
What was LiveOne, Inc.'s revenue in fiscal 2026?
LiveOne, Inc. reported revenue of $77.1M for fiscal 2026, 32.6% lower than the year before.
Was LiveOne, Inc. profitable in fiscal 2026?
No. It reported a net loss of $21.0M.
How much free cash flow did LiveOne, Inc. generate in fiscal 2026?
Cash from operations of $10.5M minus capital expenditures of $3.2M left free cash flow of -$13.7M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.